Bio-Rad Laboratories

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$653,000
$651,600
$585,400
$667,475
Gross Profit
343,400
345,300
306,000
341,912
EBITDA
-384,600
477,200
133,500
-847,400
EBIT
-418,800
426,600
95,400
-896,700
Net Income
-341,900
317,800
64,000
-715,800
Net Change In Cash
653,000
651,600
585,400
667,475
Free Cash Flow
89,200
70,800
95,500
81,248
Cash
397,800
369,300
521,400
488,100
Basic Shares
26,923
27,228
27,955
27,997

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$2,566,500
$2,671,262
$2,802,249
$2,922,545
Gross Profit
1,378,900
1,426,946
1,567,330
1,638,096
EBITDA
-2,142,000
-654,800
-4,488,959
5,588,206
EBIT
-2,293,600
-800,700
-4,666,159
5,450,606
Net Income
-1,844,200
-637,324
-3,627,535
4,254,257
Net Change In Cash
2,566,500
2,671,262
2,802,249
2,922,545
Cost of Revenue
-39,570
-195,982
Free Cash Flow
266,200
218,263
80,290
535,718
Cash
488,100
403,800
434,215
470,783
Basic Shares
28,214
29,209
29,785
30,208

Earnings Calls

QuarterEPS
2025-09-30
$2.26
2025-06-30
$2.61
2025-03-31
$2.54
2024-12-31
$2.90